Corteria Pharmaceuticals

4 trials 2 recruiting Commercial sponsor

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

0 Completed trials

7 Countries active

1 Unique IMPs

N/A Results reported

Phase II

Phase I

Phase I (Other)

Phase II: 1 Phase I: 2 Phase I (Other): 1

Oversight events:

5 temporary halts across 1 trial

View oversight register →

Top indications

Top IMPs

COR-1167 SODIUM 1

All trials

4 total

A Randomized Study in Healthy Participants to Identify the Optimal Subcutaneous Injection Strategy for COR-1167 Pending

2026-526096-31-00 Phase I (Other) 1 country
A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF COR-1389 Recruiting

2024-514853-31-00 Phase I 1 country
A Phase 1, Dose-Escalating, Randomized, Placebo-Controlled, 4-Part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of COR-1… Recruiting

2023-508543-42-00 Phase I 1 country
Corticotrophin Releasing Factor 2 Agonist For the Treatment of Worsening Heart Failure (WHF) – The CRAFT-WHF Study Halted

2024-518951-52-00 Phase II 5 countries COR-1167 SODIUM

Showing 1–4 of 4 trials

← All sponsors A–Z